by thaan thaan | Oct 14, 2025
Arthur Kirsch joined Evommune’s board of directors in October 2025. Mr. Kirsch currently serves as a board member, chairman of Audit Committee, and a member of the Compensation Committee at Liquidia Corporation (Nasdaq: LQDA). Mr. Kirsch is also a director and member...
by thaan thaan | Oct 31, 2024
Derek DiRocco has been a member of the board of directors of Evommune since October 2024 and is a Partner at RA Capital Management. Derek works on both public and private investments and serves as a member of the board of directors for 89Bio, Mineralys, Werewolf...
by evommune | Dec 5, 2023
Felice Verduyn-van Weegen has been a member of the board of directors of Evommune since September 2021 and is a Partner at EQT. Felice worked for LSP from 2015 until 2022, when LSP joined forces with EQT and became EQT Life Sciences. Prior to joining LSP, Felice...
by evommune | Dec 5, 2023
Dr. Benjamin F. McGraw has served as Chairman and a member of the Board of Directors of Evommune since October 2020. Dr. McGraw is the Executive Chairman of Perfuse Therapeutics, a clinical-stage biopharmaceutical company committed to reducing the incidence of...
by evommune | Dec 5, 2023
Rob has been a member of the board of directors of Evommune since July 2020 and is a Managing Partner at Pivotal bioVenture Partners, where he focuses on drug discovery and development investments. He has a long track record of working successfully with entrepreneurs...
